Melanie Cox
About Melanie Cox
Independent director at Revolve Group, Inc. since July 2020; serves as Lead Independent Director, Compensation Committee Chair, and Audit Committee member. Age 65; completed coursework in American Studies at the University of Texas at Austin. Tenure on RVLV board: 5+ years as of the 2025 proxy. Background spans CEO roles in retail/e-commerce, private equity advisory, and interim leadership assignments.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Backcountry.com LLC | Chief Executive Officer; Director | CEO: Jun 2020–Jan 2025; Director: Mar 2020–Jan 2025 | Led outdoor e-commerce operations during pandemic recovery and growth. |
| MBC Consulting | Founder & CEO | Apr 2017–Jun 2020; Apr 2009–Apr 2014 | Advised private equity on retail diligence; interim CEO roles at rue21 and American Laser Skincare. |
| Versa Capital Management | Managing Director; CEO (on its behalf) at Wet Seal, Inc. | Apr 2014–Mar 2017 | Operational turnaround leadership; Wet Seal later filed Chapter 11 in Feb 2018. |
| Contempo Casuals, Clothestime, Urban Outfitters, Gymboree, Scoop NYC; Prentice Capital, Cerberus | Various executive-level positions (retail/apparel/PE) | Various | Retail operations, merchandising, and PE-backed transformations. |
| rue21, inc. | Interim CEO | Date within MBC Consulting tenures | Company filed Chapter 11 in May 2017 (post-tenure engagement context). |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Federal Reserve Bank of San Francisco, Salt Lake City Branch | Board Member | Since Jan 2024 | Regional Federal Reserve branch governance role. |
| Duckhorn Portfolio, Inc. (NYSE) | Director | Current | Producer of luxury wines; public company board experience. |
Board Governance
- Current RVLV board composition: five members; Cox is Lead Independent Director; committees: Audit (member), Compensation (Chair), Nominating (chaired by CEO/Co-founder; controlled company exemption applies).
- Independence: Board determined Cox is independent under NYSE and SEC rules; she meets committee independence standards for Audit and Compensation.
- Executive sessions: Independent directors meet without management; sessions are chaired by Cox.
- Attendance: Board met 4 times in 2024; no director attended fewer than 75% of board and committee meetings.
- Controlled company status: MMMK Development (co-founders) controls ~89% voting power; RVLV relies on NYSE controlled-company exemptions (e.g., nominating committee not fully independent).
| Committee | Role | 2024 Meeting Count | Notes |
|---|---|---|---|
| Compensation | Chair | 4 | Oversees exec pay policies, goals, equity plans, clawback policy; may form subcommittees. |
| Audit | Member | 4 | Oversees financial reporting, internal controls, audit firm, related-party transactions; chair is Moser (financial expert). |
| Nominating & Corporate Governance | Not a member | 1 | Committee consists of Karanikolas (Chair) and Mente; Cox not on this committee due to controlled company structure. |
Fixed Compensation (Director)
| Year | Cash Retainer (Board) | Audit Committee (Member) | Compensation Committee (Chair) | Total Cash | Equity Award (Grant-Date Fair Value) | Total Compensation |
|---|---|---|---|---|---|---|
| 2024 | $50,000 | $7,500 | $10,000 | $67,500 | $99,983 (RSUs) | $167,498 |
- Outside director cash policy: $50k board; $7.5k audit member; $10k comp chair; $7.5k nominating chair; $3.75k nominating member. Paid quarterly.
- Director equity policy: Annual RSUs ~$100k grant-date value; vest by next AGM or 1-year anniversary; full vest on change-in-control; initial grants $50k–$100k depending on timing.
Performance Compensation (Director)
- Structure: Annual RSU grants time-based; no performance metrics disclosed for director equity (RSUs vest on time schedule, not tied to financial KPIs).
- 2024 grant detail: RSUs covering 5,567 Class A shares scheduled to vest the day prior to the 2025 annual meeting, subject to continued service.
| Grant Date | Instrument | Shares/Units | Vesting | Grant-Date Fair Value |
|---|---|---|---|---|
| 2024 award (standard annual cycle) | RSUs | 5,567 | Fully vests day prior to 2025 AGM (if in service) | $99,983 |
Other Directorships & Interlocks
| Company | Listing Status | Role | Committee Roles |
|---|---|---|---|
| Duckhorn Portfolio, Inc. | NYSE | Director | Not disclosed in RVLV proxy. |
| Federal Reserve Bank of San Francisco, Salt Lake City Branch | N/A (public institution) | Director | Not disclosed in RVLV proxy. |
- Compensation Committee interlocks: None disclosed; no RVLV executive served on boards/committees of entities with executives on RVLV’s compensation committee.
- Related party transactions: None >$120,000 involving directors in FY2024; policy requires audit committee pre-approval of related-party transactions.
Expertise & Qualifications
- Retail/e-commerce CEO experience (Backcountry; Wet Seal on behalf of Versa; interim roles at rue21, American Laser Skincare), and executive roles at Urban Outfitters, Gymboree, Scoop NYC; broad operating and merchandising pedigree.
- Private equity advisory and diligence (MBC Consulting; Versa Capital); deep restructuring/turnaround exposure.
- Public company board experience (Duckhorn Portfolio); regional Federal Reserve branch governance expertise.
- Education: Completed coursework in American Studies at the University of Texas at Austin.
Equity Ownership
| Holder | Class A Shares (Direct) | RSUs (Unvested, vest ≤60 days from record date) | Total Beneficial Class A | % of Class A Outstanding | Options |
|---|---|---|---|---|---|
| Melanie Cox | 17,535 | 5,567 | 23,102 | ~0.057% (23,102 / 40,390,960) | None disclosed |
- Voting power: Less than 1% of total voting power (co-founders control via Class B).
- Hedging/pledging: RVLV policy prohibits hedging and certain types of pledging by directors. No pledging disclosed for Cox.
- Director stock ownership guidelines: Nominating committee may consider director ownership policies; specific guideline multiples or compliance status not disclosed.
Governance Assessment
- Board roles and independence: As Lead Independent Director and Compensation Chair, Cox anchors independent oversight of pay, risk, and executive sessions—material for board effectiveness in a controlled company.
- Attendance and engagement: Company reports no director fell below 75% attendance in 2024; Cox sits on two active committees (Audit and Compensation), indicating ongoing engagement.
- Pay alignment signals: Director compensation is balanced (cash + time-vested RSUs) with standard annual ~$100k equity, aligning director interests with shareholders without performance targets that could distort oversight.
- Compensation committee practices: Independent committee chaired by Cox; periodic use of consultants (Compensia for outside director framework; no external consultant engaged for 2024 executive review), with clawback policy in place.
- Say-on-Pay support: 2024 say-on-pay received ~99% approval, reflecting investor confidence in compensation governance under Cox’s committee leadership.
- Related-party oversight: Audit committee reviews related-party transactions; none >$120k in FY2024, reducing conflict risk.
Risk Indicators & Red Flags
- Controlled company exemption reduces certain governance protections (e.g., non-independent nominating committee), making robust independent leadership (Cox’s roles) crucial.
- Prior association with Chapter 11 filings (rue21, Wet Seal) may attract scrutiny; context indicates turnaround engagements in distressed retail.
- No disclosed director performance-based equity metrics (neutral/positive for governance independence); no hedging/pledging allowed (alignment positive).
Overall Implications
- Cox’s deep retail and PE restructuring expertise strengthens compensation oversight and risk management in a founder-controlled structure; committee leadership and independent sessions are positives for investor confidence.
- Lack of related-party transactions and strong say-on-pay support mitigate conflict concerns; prior bankruptcy-linked roles warrant monitoring but are consistent with turnaround credentials.